Medpace Holdings, Inc. — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-02-10

Reporting Person: GEIGER JESSE J (CFO & COO, Lab Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-10	Common Stock	M	4000	$23	Acquired	10382	Direct
2021-02-10	Common Stock	S	4000	$160	Disposed	6382	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-10	Employee Stock Option (Right to Buy)	$23.00	M	4000	Disposed	2023-08-10	Common Stock (4000)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2: Each option vested on August 10, 2020.